Dengue Virus Complex Antibody, clone D3-2H2-9-21 | EMD Millipore MAB8705 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

EMD Millipore

other brands :

Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava

product type :

antibody

product name :

Dengue Virus Complex Antibody, clone D3-2H2-9-21

catalog :

MAB8705

quantity :

100 μg

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

D3-2H2-9-21

reactivity :

Dengue virus, human

application :

immunocytochemistry, immunoprecipitation

citations: 23

Published Application/Species/Sample/Dilution	Reference
immunocytochemistry; human; loading ...; fig 1	Liu P, Ridilla M, Patel P, Betts L, Gallichotte E, Shahidi L, et al. Beyond attachment: Roles of DC-SIGN in dengue virus infection. Traffic. 2017;18:218-231 pubmed publisher
immunocytochemistry; Dengue virus; loading ...; fig 7d	Shu Q, Lennemann N, Sarkar S, Sadovsky Y, Coyne C. ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry. PLoS Pathog. 2015;11:e1005150 pubmed publisher
	Baidaliuk A, Miot E, Lequime S, Moltini Conclois I, Delaigue F, Dabo S, et al. Cell-Fusing Agent Virus Reduces Arbovirus Dissemination in Aedes aegypti Mosquitoes In Vivo. J Virol. 2019;93: pubmed publisher
	Jitobaom K, Tongluan N, Smith D. Involvement of voltage-dependent anion channel (VDAC) in dengue infection. Sci Rep. 2016;6:35753 pubmed publisher
	Fontaine A, Jiolle D, Moltini Conclois I, Lequime S, Lambrechts L. Excretion of dengue virus RNA by Aedes aegypti allows non-destructive monitoring of viral dissemination in individual mosquitoes. Sci Rep. 2016;6:24885 pubmed publisher
	Jitoboam K, Phaonakrop N, Libsittikul S, Thepparit C, Roytrakul S, Smith D. Actin Interacts with Dengue Virus 2 and 4 Envelope Proteins. PLoS ONE. 2016;11:e0151951 pubmed publisher
	Medin C, Valois S, Patkar C, Rothman A. A plasmid-based reporter system for live cell imaging of dengue virus infected cells. J Virol Methods. 2015;211:55-62 pubmed publisher
	Higa L, Curi B, Aguiar R, Cardoso C, De Lorenzi A, Sena S, et al. Modulation of Î±-enolase post-translational modifications by dengue virus: increased secretion of the basic isoforms in infected hepatic cells. PLoS ONE. 2014;9:e88314 pubmed publisher
	de Alwis R, de Silva A. Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique. Methods Mol Biol. 2014;1138:27-39 pubmed publisher
	Thepparit C, Khakpoor A, Khongwichit S, Wikan N, Fongsaran C, Chingsuwanrote P, et al. Dengue 2 infection of HepG2 liver cells results in endoplasmic reticulum stress and induction of multiple pathways of cell death. BMC Res Notes. 2013;6:372 pubmed publisher
	Ribeiro C, Lopes V, Brasil P, Coelho J, Muniz A, Nogueira R. Perinatal transmission of dengue: a report of 7 cases. J Pediatr. 2013;163:1514-6 pubmed publisher
	Carrington L, Armijos M, Lambrechts L, Scott T. Fluctuations at a low mean temperature accelerate dengue virus transmission by Aedes aegypti. PLoS Negl Trop Dis. 2013;7:e2190 pubmed publisher
	Carrington L, Seifert S, Armijos M, Lambrechts L, Scott T. Reduction of Aedes aegypti vector competence for dengue virus under large temperature fluctuations. Am J Trop Med Hyg. 2013;88:689-97 pubmed publisher
	Vega Almeida T, Salas Benito M, De Nova Ocampo M, del Angel R, Salas Benito J. Surface proteins of C6/36 cells involved in dengue virus 4 binding and entry. Arch Virol. 2013;158:1189-207 pubmed publisher
	Juárez Martínez A, Vega Almeida T, Salas Benito M, García Espitia M, De Nova Ocampo M, del Angel R, et al. Detection and sequencing of defective viral genomes in C6/36 cells persistently infected with dengue virus 2. Arch Virol. 2013;158:583-99 pubmed publisher
	Barr K, Messenger A, Anderson B, Friary J, Heil G, Reece K, et al. Recovery of live virus after storage at ambient temperature using ViveST™. J Clin Virol. 2013;56:57-61 pubmed publisher
	Mustafa B, Hani A, Chem Y, Mariam M, Khairul A, Abdul Rasid K, et al. Epidemiological and clinical features of dengue versus other acute febrile illnesses amongst patients seen at government polyclinics. Med J Malaysia. 2010;65:291-6 pubmed
	Chua K, Mustafa B, Abdul Wahab A, Chem Y, Khairul A, Kumarasamy V, et al. A comparative evaluation of dengue diagnostic tests based on single-acute serum samples for laboratory confirmation of acute dengue. Malays J Pathol. 2011;33:13-20 pubmed
	Kaptein S, De Burghgraeve T, Froeyen M, Pastorino B, Alen M, Mondotte J, et al. A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Agents Chemother. 2010;54:5269-80 pubmed publisher
	Salgado D, Eltit J, Mansfield K, Panqueba C, Castro D, Vega M, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J. 2010;29:238-42 pubmed publisher
	Lambrechts L, Chevillon C, Albright R, Thaisomboonsuk B, Richardson J, Jarman R, et al. Genetic specificity and potential for local adaptation between dengue viruses and mosquito vectors. BMC Evol Biol. 2009;9:160 pubmed publisher
	Goncalvez A, Engle R, St Claire M, Purcell R, LAI C. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A. 2007;104:9422-7 pubmed publisher
	de Macedo F, Nicol A, Cooper L, Yearsley M, Pires A, Nuovo G. Histologic, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive immunohistochemistry. Diagn Mol Pathol. 2006;15:223-8 pubmed

product information

Catalog Number :

MAB8705

Subcategory :

Infectious Diseases

Product Name :

Anti-Dengue Virus Complex Antibody, clone D3-2H2-9-21

Product Type :

Antibodies

Clonality :

Monoclonal Antibody

Host Name :

Mouse

Antigen :

Dengue Virus Complex

Clone :

D3-2H2-9-21

Conjugate :

Purified

Isotype :

IgG2a

Product Description :

Anti-Dengue Virus Complex Antibody, clone D3-2H2-9-21

Cross Reactivity :

Human

Background :

Dengue fever is an acute, mosquito-transmitted viral disease characterized by fever, headache, arthralgia (severe retro-orbital pain), myalgia, rash, nausea, and vomiting. Infections are caused by any of the four closely related, but antigenically distinct virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). Infection with one of these serotypes does not provide cross-protective immunity, so persons living in a dengue-endemic area can have four dengue infections during their lifetimes. Dengue is primarily an urban disease of the tropics, and the viruses that cause it are maintained in a cycle that involves humans and Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans. Although most dengue infections result in relatively mild illness, some can produce Dengue Hemorrhagic Fever (DHF) or dengue shock syndrome, with children being particularly at risk. Although epidemic outbreaks have been reported since 1779, the incidence has been increasing, with global, multiple serotype pandemics intensifying within the last 15 years. There is no specific antiviral therapy for dengue, but for both classical dengue and dengue hemorrhagic fever, symptomatic and supportive measures are effective. Important risk factors for DHF include the strain and serotype of the virus involved, as well as the age, immune status, and genetic predisposition of the patient.

Immunogen :

Dengue type 4 virus antigens.

Specificity :

Reacts with all members of the Dengue complex.

Package Size :

100 μg

Uses :

Immunocytochemistry;Immunofluorescence

Storage :

Maintain for 6 months at 2–8°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.